Corden Pharma

Plankstadt, DE · Caponago, IT · Boulder, CO
Find alternatives to Corden Pharma for mRNA →
Program data pending ClinicalTrials.gov matching · Last scored 2026-11-02
83.1
Signal Score
✓ FDA Inspections (5) ○ Clinical Trials ○ SEC Filings ✓ Press (1) ✓ EMA GMP (17) ○ MHRA GMP ✓ HC GMP (31)

Quick Facts: Corden Pharma

Signal Score
83.1/100 (as of 2026-11-02)
Quality Compliance
99.3/100 — Clean EMA record: 17 active GMP certificates (no deductions)
Headquarters
Plankstadt, DE · Caponago, IT · Boulder, CO
Modalities
mRNA, Oligonucleotide, Biologics
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Corden Pharma

Manufactured lipids for BioNTech COVID vaccine.

Signal Score & Pillar Breakdown

Quality Compliance 99.3
Clean EMA record: 17 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 17 active GMP certificates (no deductions)
FDA Inspections5 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-11-14)
EMA GMP Certificates17 on record
Most Recent HC OutcomeCompliant · 2025-11-10
HC Attribution31 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Clean EMA record: 17 active GMP certificates (no deductions)
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesmRNA, Oligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: ICIG
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: ICIG
Financial assessment: 68.0/100
Capacity 70.0
Multi-site operations (6 manufacturing sites)
Sites: Plankstadt, Germany, Caponago, Italy, Boulder, CO, Chenôve, France, Amadora, Portugal, Frankfurt am Main, Germany
Source: company profiles (manufacturing sites, modality breadth)
6 manufacturing sites
Press Signals1 articles (not scored)
Multi-site operations (6 manufacturing sites)

Corden Pharma FDA Inspection History

2025-11
2025-10
2025-03
2022-12
2022-09
NAI VAI OAI
Date Site Type 483 citations posted Classification
2025-11-14
Corden Pharma Colorado, Inc.
Boulder, Colorado Facility-linked
Drug Quality Assurance Not posted No Action Indicated (NAI)
2025-10-15
Corden Pharma GmbH
Plankstadt Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2025-03-28
Corden Pharma S.p.A.
Caponago Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2022-12-02
Corden Pharma S.p.A.
Caponago Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
2022-09-14
Corden Pharma GmbH
Plankstadt Facility-linked
Drug Quality Assurance Not posted Voluntary Action Indicated (VAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

Corden Pharma EMA GMP Compliance 17 certificates

2025-10
2025-10
2025-05
2025-03
2025-03
2025-03
2025-03
2025-03
2025-03
2025-03
2024-10
2024-03
2022-11
2021-11
2019-04
2019-04
2019-04
Compliant Non-Compliant
Certificate Site Country Inspection Date Status
DE_BW_01_GMP_2025_0261 Corden Pharma GmbH Germany 2025-10-15 COMPLIANT
DE_BW_01_GMP_2025_0260 Corden Pharma GmbH Germany 2025-10-15 COMPLIANT
2025_HPF_FR_090 Corden Pharma Chenove France 2025-05-15 COMPLIANT
IT/80/H/2025 Corden Pharma S.p.A. Italy 2025-03-28 COMPLIANT
IT/121/H/2026 Corden Pharma S.p.A. Italy 2025-03-28 COMPLIANT
IT/148/H/2026 Corden Pharma S.p.A. Italy 2025-03-28 COMPLIANT
F022/S1/MH/001/2026 Corden Pharma Lisbon S.A. Portugal 2025-03-21 COMPLIANT
F022/S2/MH/001/2026 Corden Pharma Lisbon S.A. Portugal 2025-03-21 COMPLIANT
F022/S2/ME/001/2026 Corden Pharma Lisbon S.A. Portugal 2025-03-21 COMPLIANT
F022/S1/ME/001/2026 Corden Pharma Lisbon S.A. Portugal 2025-03-21 COMPLIANT
DE_HE_01_GMP_2026_0198 Corden Pharma International GmbH Germany 2024-10-10 COMPLIANT
NBF/25/2024/V Corden Pharma S.p.A. Italy 2024-03-01 COMPLIANT
IT-API/44/H/2023 Corden Pharma Latina S.p.A. Italy 2022-11-23 COMPLIANT
IT-API/5/H/2022 Corden Pharma Latina S.p.A. Italy 2021-11-16 COMPLIANT
IT-API/23/H/2020 CORDEN PHARMA LATINA S.P.A. Italy 2019-04-05 COMPLIANT
IT-API/39/H/2021 CORDEN PHARMA LATINA S.P.A. Italy 2019-04-05 COMPLIANT
IT-API/47/H/2021 CORDEN PHARMA LATINA S.P.A. Italy 2019-04-05 COMPLIANT
Source: EMA EudraGMDP · Retrieved Nov 21, 2026

Japan-accredited overseas site (PMDA)

sterile, general (non-sterile) · 4 sites

  • Plankstadt, Germany · Corden Pharma GmbH — general (non-sterile) · valid to May 12, 2028
  • Caponago, Italy · Corden Pharma S.p.A. — sterile · valid to Jul 30, 2029
  • Boulder, United States · Corden Pharma Colorado, Inc. (2 sites) — general (non-sterile) · valid to Sep 30, 2027

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 20, 2026

Company Signals 1 articles

Company announcements, not verified evidence. They do not change any score.
facility_expansion 2026-03-19
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion - CHEManager
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion  CHEManager.

Frequently Asked Questions About Corden Pharma

How many FDA inspections does Corden Pharma have on record?
CDMO Signal tracks 5 FDA inspections for Corden Pharma, sourced from the FDA inspection database. See the full inspection history above.
Has Corden Pharma received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Corden Pharma.
Does Corden Pharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 17 EMA GMP certificates for Corden Pharma.
What is Corden Pharma's CDMO Signal Score?
Corden Pharma has a Signal Score of 83/100, based on quality, operations, financial stability, and capacity data.
Evaluating Corden Pharma for a manufacturing program?
Use the free AI matchmaker to compare Corden Pharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
mRNA CDMOs → Oligonucleotide CDMOs → Biologics CDMOs →

Similar CDMOs

Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 90.1
Biologics, mRNA, Small Molecule API, Oral Solid Dose, High-Potency APIs, Sterile Fill-Finish
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy

Compare Corden Pharma with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Corden Pharma
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.